{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:45:26Z","timestamp":1760298326849,"version":"3.41.2"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1111\/igc.0b013e3181ca5df3","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T14:22:09Z","timestamp":1291386129000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Type-Specific Human Papillomavirus Incidence on Screening Performance and Cost"],"prefix":"10.1016","volume":"20","author":[{"given":"Theodoros","family":"Agorastos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Sotiriadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos J.","family":"Emmanouilides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.283.1.87","article-title":"HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica","volume":"283","author":"Schiffman","year":"2000","journal-title":"JAMA."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0020","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0025","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/djn065","article-title":"Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test","volume":"100","author":"Ronco","year":"2008","journal-title":"J Natl Cancer Inst."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0035","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus\u2013like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0040","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus\u2013like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0050","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus\u2013like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0055","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/j.vaccine.2006.05.109","article-title":"Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries","volume":"24","author":"Lehtinen","year":"2006","journal-title":"Vaccine."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0060","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0065","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.ygyno.2007.07.021","article-title":"The New Technologies for Cervical Cancer screening randomised controlled trial. An overview of results during the first phase of recruitment","volume":"107","author":"Ronco","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0070","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/dji162","article-title":"Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, the Netherlands, France, and Italy","volume":"97","author":"Kim","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0075","doi-asserted-by":"crossref","first-page":"K42","DOI":"10.1016\/j.vaccine.2008.05.002","article-title":"New technologies in cervical cancer screening","volume":"26","author":"Gravitt","year":"2008","journal-title":"Vaccine."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0080","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.bjc.6602049","article-title":"Cervical HPV infection and neoplasia in a large population\u2013based prospective study: the Manchester cohort","volume":"91","author":"Peto","year":"2004","journal-title":"Br J Cancer."},{"key":"10.1111\/IGC.0b013e3181ca5df3_bb0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-0528.2007.01265.x","article-title":"Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia","volume":"114","author":"Coupe","year":"2007","journal-title":"BJOG."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181ca5df3","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24036065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24036065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:34:07Z","timestamp":1753223647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24036065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1048891X24036065"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181ca5df3","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Type-Specific Human Papillomavirus Incidence on Screening Performance and Cost","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181ca5df3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}